Novo Nordisk to slash Wegovy prices by 50%, Ozempic by 35%
CBS News • • business
Key Points:
- Novo Nordisk announced it will reduce prices for its weight-loss drugs Wegovy and Ozempic by up to 50%, with prices set at $675 per month starting January 2027.
- The price cut includes a 50% reduction for Wegovy and a 35% reduction for Ozempic, and the company will also offer Rybelsus, a diabetes pill sometimes used for weight loss, at the same price.
- This move aims to enhance affordability amid growing competition from Eli Lilly's Mounjaro and Zepbound, as well as other GLP-1 treatments entering the market.
- Novo Nordisk emphasized that the price reductions target out-of-pocket costs for patients with high-deductible insurance
